{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,1]],"date-time":"2026-02-01T08:46:37Z","timestamp":1769935597236,"version":"3.49.0"},"reference-count":25,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2023,2,1]],"date-time":"2023-02-01T00:00:00Z","timestamp":1675209600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,2,1]],"date-time":"2023-02-01T00:00:00Z","timestamp":1675209600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,2,1]],"date-time":"2023-02-01T00:00:00Z","timestamp":1675209600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2023,2,1]],"date-time":"2023-02-01T00:00:00Z","timestamp":1675209600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2023,2,1]],"date-time":"2023-02-01T00:00:00Z","timestamp":1675209600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2023,2,1]],"date-time":"2023-02-01T00:00:00Z","timestamp":1675209600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2023,2,1]],"date-time":"2023-02-01T00:00:00Z","timestamp":1675209600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["21976008"],"award-info":[{"award-number":["21976008"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["U1967216"],"award-info":[{"award-number":["U1967216"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Bioorganic & Medicinal Chemistry Letters"],"published-print":{"date-parts":[[2023,2]]},"DOI":"10.1016\/j.bmcl.2023.129154","type":"journal-article","created":{"date-parts":[[2023,1,31]],"date-time":"2023-01-31T02:58:41Z","timestamp":1675133921000},"page":"129154","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":4,"special_numbering":"C","title":["Improving tumor\/muscle and tumor\/blood ratios of 99mTc-labeled nitroimidazole propylene amine oxime (PnAO) complexes with ethylene glycol linkers"],"prefix":"10.1016","volume":"82","author":[{"given":"Shuo","family":"Li","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Taiwei","family":"Chu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.bmcl.2023.129154_b0005","doi-asserted-by":"crossref","first-page":"266","DOI":"10.1093\/jnci\/93.4.266","article-title":"Tumor hypoxia: Definitions and current clinical, biologic, and molecular aspects","volume":"93","author":"H\u00f6ckel","year":"2001","journal-title":"J Natl Cancer Inst"},{"key":"10.1016\/j.bmcl.2023.129154_b0010","doi-asserted-by":"crossref","first-page":"695","DOI":"10.1016\/0360-3016(84)90301-8","article-title":"Hypoxic fractions of solid tumors: Experimental techniques, methods of analysis, and a survey of existing data","volume":"10","author":"Moulder","year":"1984","journal-title":"J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.bmcl.2023.129154_b0015","doi-asserted-by":"crossref","first-page":"593","DOI":"10.1002\/path.5402","article-title":"Recent advances in the biology of tumour hypoxia with relevance to diagnostic practice and tissue-based research","volume":"250","author":"Macklin","year":"2020","journal-title":"J Pathol"},{"key":"10.1016\/j.bmcl.2023.129154_b0020","doi-asserted-by":"crossref","first-page":"6160","DOI":"10.1021\/acs.chemrev.6b00525","article-title":"Chemical design and synthesis of functionalized probes for imaging and treating tumor hypoxia","volume":"117","author":"Liu","year":"2017","journal-title":"Chem Rev"},{"key":"10.1016\/j.bmcl.2023.129154_b0025","doi-asserted-by":"crossref","unstructured":"Giglio J, Rey A. 99mTc labelling strategies for the development of potential nitroimidazolic hypoxia imaging agents. Inorganics. 2019; 7. https:\/\/doi.org\/10.3390\/inorganics7110128.","DOI":"10.3390\/inorganics7110128"},{"key":"10.1016\/j.bmcl.2023.129154_b0030","doi-asserted-by":"crossref","first-page":"1637","DOI":"10.1063\/1.555843","article-title":"Reduction potentials of one-electron couples involving free radicals in aqueous solution","volume":"18","author":"Wardman","year":"1989","journal-title":"J Phys Chem Ref Data"},{"key":"10.1016\/j.bmcl.2023.129154_b0035","first-page":"1023","article-title":"In vitro and in vivo evaluation of a technetium-99m-labeled 2-nitroimidazole (BMS181321) as a marker of tumor hypoxia","volume":"37","author":"Ballinger","year":"1996","journal-title":"J Nucl Med"},{"key":"10.1016\/j.bmcl.2023.129154_b0040","first-page":"169","article-title":"BRU59-21, a second-generation 99mTc-labeled 2-nitroimidazole for imaging hypoxia in tumors","volume":"41","author":"Melo","year":"2000","journal-title":"J Nucl Med"},{"key":"10.1016\/j.bmcl.2023.129154_b0045","doi-asserted-by":"crossref","first-page":"172","DOI":"10.1016\/j.bmcl.2011.11.042","article-title":"Effect of a second nitroimidazole redox centre on the accumulation of a hypoxia marker: Synthesis and in vitro evaluation of 99mTc-labeled bisnitroimidazole propylene amine oxime complexes","volume":"22","author":"Huang","year":"2012","journal-title":"Bioorganic Med Chem Lett"},{"key":"10.1016\/j.bmcl.2023.129154_b0050","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1007\/s41365-016-0028-3","article-title":"Synthesis, radiolabeling and biological evaluation of butene amine oxime containing nitrotriazole as a tumor hypoxia marker","volume":"27","author":"Zhang","year":"2016","journal-title":"Nucl Sci Tech"},{"key":"10.1016\/j.bmcl.2023.129154_b0055","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1002\/jlcr.3365","article-title":"In vitro and in vivo evaluation of technetium-99m-labeled propylene amine oxime complexes containing nitroimidazole and nitrotriazole groups as hypoxia markers","volume":"59","author":"Zhang","year":"2016","journal-title":"J Labelled Compd Radiopharm"},{"key":"10.1016\/j.bmcl.2023.129154_b0060","doi-asserted-by":"crossref","first-page":"238","DOI":"10.1021\/bc060239q","article-title":"Fluoro-pegylated (FPEG) imaging agents targeting A\u03b2 aggregates","volume":"18","author":"Stephenson","year":"2007","journal-title":"Bioconjugate Chem"},{"key":"10.1016\/j.bmcl.2023.129154_b0065","doi-asserted-by":"crossref","first-page":"5593","DOI":"10.1021\/acs.jmedchem.0c01962","article-title":"Development of novel 18F-PET agents for tumor hypoxia imaging","volume":"64","author":"Wang","year":"2021","journal-title":"J Med Chem"},{"key":"10.1016\/j.bmcl.2023.129154_b0070","doi-asserted-by":"crossref","first-page":"943","DOI":"10.1007\/s10967-019-06649-9","article-title":"Synthesis and bioevaluation of novel radioiodinated PEG-modified 2-nitroimidazole derivatives for tumor hypoxia imaging","volume":"321","author":"Wang","year":"2019","journal-title":"J Radioanal Nucl Chem"},{"key":"10.1016\/j.bmcl.2023.129154_b0075","doi-asserted-by":"crossref","first-page":"2544","DOI":"10.1021\/acsabm.0c01555","article-title":"Successful application of CuAAC click reaction in constructing 64Cu-labeled antibody conjugates for immuno-PET imaging","volume":"4","author":"Lee","year":"2021","journal-title":"ACS Appl Bio Mater"},{"key":"10.1016\/j.bmcl.2023.129154_b0080","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1021\/acs.molpharmaceut.1c00712","article-title":"Preparation and bioevaluation of 99mTc-labeled FAP inhibitors as tumor radiotracers to target the fibroblast activation protein","volume":"19","author":"Ruan","year":"2022","journal-title":"Mol Pharm"},{"key":"10.1016\/j.bmcl.2023.129154_b0085","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1007\/s10967-017-5210-5","article-title":"Synthesis of novel PEG-modified nitroimidazole derivatives via \u201chot-click\u201d reaction and their biological evaluation as potential PET imaging agent for tumors","volume":"312","author":"Cao","year":"2017","journal-title":"J Radioanal Nucl Chem"},{"key":"10.1016\/j.bmcl.2023.129154_b0090","doi-asserted-by":"crossref","first-page":"4145","DOI":"10.1021\/ic0497634","article-title":"Modeling novel radiopharmaceuticals: Mono-C6-substituted PnAO ligands (PnAO = 3,3,9,9-tetramethyl-4,8-diazaundecane-2,10-dione dioxime)","volume":"43","author":"Walker","year":"2004","journal-title":"Inorg Chem"},{"key":"10.1016\/j.bmcl.2023.129154_b0095","doi-asserted-by":"crossref","first-page":"2106","DOI":"10.1021\/acs.molpharmaceut.9b00069","article-title":"Development and evaluation of an 18F-radiolabeled monocyclam derivative for imaging CXCR4 expression","volume":"16","author":"Brickute","year":"2019","journal-title":"Mol Pharm"},{"key":"10.1016\/j.bmcl.2023.129154_b0100","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1016\/j.nucmedbio.2020.12.008","article-title":"Effects of 18F-fluorinated neopentyl glycol side-chain on the biological characteristics of stilbene amyloid-\u03b2 PET ligands","volume":"94\u201395","author":"Tago","year":"2021","journal-title":"Nucl Med Biol"},{"key":"10.1016\/j.bmcl.2023.129154_b0105","first-page":"18","article-title":"Evaluation of 99mTc-MAG3-2-nitroimidazole for hypoxic tumor imaging","volume":"5","author":"Lee","year":"2019","journal-title":"J Radiopharm Mol Probes"},{"key":"10.1016\/j.bmcl.2023.129154_b0110","doi-asserted-by":"crossref","first-page":"3704","DOI":"10.1016\/j.bmcl.2013.05.015","article-title":"Synthesis and biological evaluation of a novel 99mTc labeled 2-nitroimidazole derivative as a potential agent for imaging tumor hypoxia","volume":"23","author":"Joyard","year":"2013","journal-title":"Bioorganic Med Chem Lett"},{"key":"10.1016\/j.bmcl.2023.129154_b0115","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1007\/s10967-015-4135-0","article-title":"Neutral 99mTc(CO)3 complexes of \u201cclicked\u201d nitroimidazoles for the detection of tumor hypoxia","volume":"307","author":"Bhadwal","year":"2016","journal-title":"J Radioanal Nucl Chem"},{"key":"10.1016\/j.bmcl.2023.129154_b0120","doi-asserted-by":"crossref","unstructured":"Ruan Q, Zhang X, Lin X, et al. Novel 99mTc labelled complexes with 2-nitroimidazole isocyanide: Design, synthesis and evaluation as potential tumor hypoxia imaging agents. MedChemComm. 2018;9:988\u2013994. https:\/\/doi.org\/10.1039\/C8MD00146D.","DOI":"10.1039\/C8MD00146D"},{"key":"10.1016\/j.bmcl.2023.129154_b0125","doi-asserted-by":"crossref","first-page":"1013","DOI":"10.1007\/s10967-014-3038-9","article-title":"Synthesis and preliminary biological evaluation of 99mTc(CO)3-labeled pegylated 2-nitroimidazoles","volume":"300","author":"Wang","year":"2014","journal-title":"J Radioanal Nucl Chem"}],"container-title":["Bioorganic & Medicinal Chemistry Letters"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0960894X2300032X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0960894X2300032X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,18]],"date-time":"2025-10-18T07:46:27Z","timestamp":1760773587000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0960894X2300032X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,2]]},"references-count":25,"alternative-id":["S0960894X2300032X"],"URL":"https:\/\/doi.org\/10.1016\/j.bmcl.2023.129154","relation":{},"ISSN":["0960-894X"],"issn-type":[{"value":"0960-894X","type":"print"}],"subject":[],"published":{"date-parts":[[2023,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Improving tumor\/muscle and tumor\/blood ratios of 99mTc-labeled nitroimidazole propylene amine oxime (PnAO) complexes with ethylene glycol linkers","name":"articletitle","label":"Article Title"},{"value":"Bioorganic & Medicinal Chemistry Letters","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bmcl.2023.129154","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"129154"}}